Advanced Medical Solutions Group plc (FRA:AQA)

Market Cap	703.47M +33.0%
Revenue (ttm)	262.43M +29.0%
Net Income	11.41M +40.3%
EPS	0.05 +39.1%
Shares Out	n/a
PE Ratio	61.65
Forward PE	20.10
Dividend	0.03 (1.02%)
Ex-Dividend Date	May 28, 2026

Volume	n/a
Open	3.180
Previous Close	2.960
Day's Range	3.180 - 3.220
52-Week Range	2.180 - 3.220
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 1, 2026

About FRA:AQA

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally. It offers surgical products, such as tissue adhesives, sutures and clips, haemostats, biosurgical, internal fixation devices, infection control, and internal sealants under INTEGUSEAL, LiquiBand, RESORBA, LiquiBandFix8, and Seal-G, Vitalitec, and ActivHeal brand names. The company provid...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1991
• Employees: 1,800
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AQA

Financial Performance

In 2025, FRA:AQA's revenue was 228.94 million, an increase of 28.96% compared to the previous year's 177.52 million. Earnings were 9.95 million, an increase of 40.32%.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error